Europe — EMA

Oltar (Glimepiride)

Glimepiride, the active ingredient in Oltar, is a sulfonylurea presented as a tablet for oral use. It treats type 2 diabetes mellitus in adults by improving blood glucose control.

Glimepiride

Request sourcing

Pack/s

What is Glimepiride?

Glimepiride, the active ingredient in Oltar, is a sulfonylurea presented as a tablet for oral use. It treats type 2 diabetes mellitus in adults by improving blood glucose control. GNH USA supplies Oltar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oltar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Glimepiride used for?

Glimepiride is used to manage hyperglycaemia in type 2 diabetes mellitus, acting on pancreatic beta‑cell function.

- Type 2 Diabetes Mellitus: Improves fasting and post‑prandial glucose levels. - Adjunct to Diet and Exercise: Enhances overall glycaemic control when combined with lifestyle measures. - Combination Therapy: Can be co‑prescribed with metformin or other oral antidiabetics for additional glucose lowering.

What are the side effects of Glimepiride?

Glimepiride may exhibit different effects depending on individual patient responses.

Common Side Effects: - Hypoglycaemia - ... ... ... ... ... ... ... ... ... ... ... ... ... ... - ... ... ... ... ... ... ... ... ... ... ... ... ... ... - ... .... ... ... .... ... t... ... ... ... ... ... ... ... ... ... ... ... ... ... t… .... ... ... ...

What precautions apply to Glimepiride?

The ... ... ... ... ... ... ... ... ... t .... ... t ewline … ewline … … ... ... ... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →